Effects of monoamine reuptake inhibitors on wet-dog shakes mediated by 5-HT2A receptors in ACTH-treated rats

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 1, 2005, Pages 65-70

  Kawakami, Yasuhiro ^a   Kitamura, Yoshihisa ^a   Araki, Hiroaki ^b   Kitagawa, Kouhei ^a   Suemaru, Katsuya ^b   Shibata, Kazuhiko ^a   Gomita, Yutaka ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 HT 2A receptor; ACTH; Bupropion; Desipramine; DOI; Fluvoxamine; Imipramine; Mazindol; Wet dog shake

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; AMFEBUTAMONE; CATECHOLAMINE; CORTICOTROPIN; DESIPRAMINE; DOPAMINE UPTAKE INHIBITOR; FLUVOXAMINE; IMIPRAMINE; MAZINDOL; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; DRUG SELECTIVITY; INHIBITION KINETICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WET DOG SHAKES;

ADRENERGIC UPTAKE INHIBITORS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; NEUROTRANSMITTER UPTAKE INHIBITORS; RATS; RATS, WISTAR; RECEPTOR, SEROTONIN, 5-HT2A; SEROTONIN UPTAKE INHIBITORS; TREMOR;

CANIS FAMILIARIS;

EID: 19344362321     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.02.010     Document Type: Article

References (21)

1. J.A. Ascher, J.O. Cole, J.N. Colin, J.P. Feighner, R.M. Ferris, and H.C. Fibiger Bupropion: a review of its mechanism of antidepressant activity J Clin Psychiatry 56 1995 395 401
2. P. Bedard, and C.J. Pycock Wet-dog shake behavior in the rat: a possible quantitative model of central 5-hydroxytrptamine activity Neuropharmacology 16 1977 663 670
3. D.A. Bergstrom, and K.J. Kellar Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment J Pharmacol Exp Ther 209 1979 256 261
4. 2 receptor function in the brain of the guinea pig Neuropharmacology 32 1993 249 256
5. 3H-dopamine by rat striatal synaptosomes Naunyn Schmiedebergs Arch Pharmacol 298 1977 1 5
6. 2-mediated behavior in the rat following noradrenergic or serotonergic denervation J Neural Transm [GenSesct] 84 1991 19 32
7. 2-adrenergic, imipramine and dopaminergic receptors in brain Neuropharmacology 22 1983 1257 1267
8. 3H-biogenic amines in rat brain tissue slices Eur J Pharmacol 45 1977 329 333
9. W.J. Houlihan, J.W. Boja, V.A. Parrino, T.A. Kopajtic, and M.J. Kuhar Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter J Med Chem 39 1996 4935 4941
10. T. Ishikane, T. Koyama, S. Matsubara, Y. Odagaki, R. Matsubara, and I. Yamashita Pharmacological properties of new antidepressants, fluvoxamine (SME3110): effects on extracellular levels of monoamine in vivo and monoaminergic receptors in rat brain Jpn J Neuropsychopharmacol 16 1994 37 43
11. 2A receptor in ACTH-treated rats Pharmacol Biochem Behav 72 2002 397 402
12. 2 receptor-mediated wet-dog shake Psychopharmacology 108 1992 27 32
13. 2) and β-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment J Psychiatry Neurosci 16 1991 209 214
14. Q. Li, M.S. Brownfield, G. Battaglia, T.M. Cabrera, A.D. Levy, and P.A. Rittenhouse Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperrazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4- lodophenyl)-2-aminopropane HCl (DOI) J Pharmacol Exp Ther 266 1993 836 844
15. J. Maj, Z. Rogoz, and G. Skuza Fluvoxamine, a new antidepressant drug, fails to show antiserotonin activity Eur J Pharmacol 81 1982 287 292
16. 2 receptors following chronic administration of imipramine Neuropharmacology 23 1984 1265 1269
17. L. Pawlowski, and M. Melzacka Inhibition of head twitch response to quipazine in rats by chronic amitriptyline but not fluvoxamine or citalopram Psychopharmacology 88 1986 279 284
18. S.J. Peroutka, and S.H. Snyder Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding Science 210 1980 88 90
19. 3H]spiroperidol by chronic treatment with the antidepressant amitriptyline J Pharmacol Exp Ther 215 1980 582 587
20. 2 receptor binding and on the receptor-mediated behavioral response of rats Eur J Pharmacol 333 1997 123 128
21. 2 receptor mediated c-fos gene expression Eur J Pharmacol 290 1995 263 266